Breast Neoplasms: all 12,820 studies
Page 22 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Impact of Regional Anesthesia on Chronic Post-operative PainEnrolling by invitationNCT05876390
- Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) CancerRecruitingNCT05874492Not applicable
- Comparison of AT & PR Training to Improve Functional Ability After Breast Cancer SurgeryRecruitingNCT05873036Not applicable
- Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast CancerNot yet recruitingNCT05872412Phase 2
- IKS014 in Advanced Solid Tumors That Express HER2RecruitingNCT05872295Phase 1
- Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier GranulesNot yet recruitingNCT05871437Phase 4
- CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast CancerRecruitingNCT05870813
- PRE-ISPY Phase I/II Oncology Platform ProgramRecruitingNCT05868226Phase 1/2
- Psychoneurological Symptom Cluster in OncologyRecruitingNCT05867966Not applicable
- Study of AVZO-021 in Patients With Advanced Solid TumorsRecruitingNCT05867251Phase 1/2
- Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing LumpectomyRecruitingNCT05866458
- Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain MetastasesRecruitingNCT05866432Phase 2
- The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBCNot yet recruitingNCT05862610Phase 2
- Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)RecruitingNCT05861830Phase 3
- The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 ExpressionRecruitingNCT05861635Phase 4
- Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast CancerRecruitingNCT05861271Phase 2
- Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral MetastasisNot yet recruitingNCT05860907Phase 4
- Promoting Physical Activity in Breast Cancer Survivors on Aromatase InhibitorsRecruitingNCT05860621Not applicable
- Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast CancerRecruitingNCT05860465Phase 2/3
- Influence of Body Composition on Chemotherapy Outcomes in Localized Breast CancerRecruitingNCT05858398Not applicable
- Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast CancerRecruitingNCT05858242
- Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton TherapyRecruitingNCT05856773Phase 3
- Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABCRecruitingNCT05856383
- Comparative Study Between Shear and Strain Elastography in Monitoring the Response to NAC in Breast Cancer PatientsNot yet recruitingNCT05852743
- Disitamab Vedotin (RC48-ADC) in Breast CancerRecruitingNCT05851677
- Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal StudyRecruitingNCT05851053
- A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast CancerRecruitingNCT05851014Phase 3
- Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast CancersRecruitingNCT05846789Phase 2
- A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.RecruitingNCT05845138Phase 1/2
- Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast CancerNot yet recruitingNCT05843292Phase 4
- Quality of Life After Conservative Oncoplastic Surgery in Breast Cancer Patients (IRONY: lIfe afteR ONcoplastic surgerY)RecruitingNCT05842148
- Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast CancerNot yet recruitingNCT05841849Phase 4
- Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast CancerNot yet recruitingNCT05841381Phase 3
- Efficacy and Safety of KN026 in Combination With HB1801 in the First-line Treatment of Subjects With HER2-positive Recurrent or Metastatic Breast Cancer.RecruitingNCT05838066Phase 3
- Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer After Neoadjuvant TherapyRecruitingNCT05838001Not applicable
- NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast CancerRecruitingNCT05837455Phase 2
- The Development of Quantitative Ultrasound Imaging Software PlatformEnrolling by invitationNCT05836246
- InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2RecruitingNCT05835739
- Pyrotinib in Women With High-risk in Early Stage Breast CancerRecruitingNCT05834764Phase 2
- Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast CancerRecruitingNCT05834582Phase 2
- Comparison Between Prepectoral and Subpectoral Breast ReconstructionRecruitingNCT05833659
- ONLOOP Trial: Evaluating a New Surveillance and Support System for Survivors of Childhood Cancer in OntarioNot yet recruitingNCT05832138Not applicable
- Extracellular Vesicles in Breast Cancer Patientsin Undergone Neoadjuvant ChemotherapyRecruitingNCT05831397
- A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid TumorsRecruitingNCT05830097Phase 1/2
- Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast CancerRecruitingNCT05823623Phase 2
- Efficacy of Interleukin-2 in Triple Negative Breast CancerNot yet recruitingNCT05821686Phase 1/2
- Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.RecruitingNCT05817227
- International Prospective REgistry on Pre-pectorAl Breast REconstructionRecruitingNCT05817175
- Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast CancerRecruitingNCT05816655Phase 2
- Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic BioimagingRecruitingNCT05809128
- Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine TherapyRecruitingNCT05809024Phase 4
- Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI TherapyNot yet recruitingNCT05806671Phase 2
- Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast CancerRecruitingNCT05804916Phase 2/3
- Using a Blood Test to Monitor Metastatic Breast Cancer TreatmentRecruitingNCT05804578
- A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast CancerNot yet recruitingNCT05802342Phase 2/3
- Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World StudyNot yet recruitingNCT05801705
- Benefits of Morphine Gel for Pain Reduction in Patients With Cancer WoundsRecruitingNCT05800834Phase 2
- Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast CancerRecruitingNCT05800756Phase 2
- Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AIRecruitingNCT05800132Not applicable
- Characterization of Extracellular Vesicles in Breast Cancer PatientsRecruitingNCT05798338
- Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast CancerRecruitingNCT05797454Not applicable
- Measuring Oncological Value of Exercise and StatinRecruitingNCT05796973Phase 3
- CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast CancerRecruitingNCT05795335
- TRUDI: TDXD+Durva in HER2+/Low IBCRecruitingNCT05795101Phase 2
- A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.Not yet recruitingNCT05792410Phase 1/2
- PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFSRecruitingNCT05792150
- Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for CancerRecruitingNCT05787834Not applicable
- A Study of DB-1310 in Advanced/Metastatic Solid TumorsRecruitingNCT05785741Phase 1/2
- Impact of Systematic Shaving on MarginsRecruitingNCT05782686Not applicable
- The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast CancerRecruitingNCT05780814Not applicable
- A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyRecruitingNCT05774951Phase 3
- Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Tissue Nanomechanical Phenotype EvaluationRecruitingNCT05774678Phase 3
- Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast IrradiationRecruitingNCT05772390Phase 2
- Circular RNA and Chemerin in Breast Cancer PatientNot yet recruitingNCT05771337
- Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical TrialsNot yet recruitingNCT05769491
- Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain MetastasesRecruitingNCT05769010Phase 2
- Ultrasound Radiomics for Predicting Breast Cancer and Axillary Lymph Node MetastasisNot yet recruitingNCT05768451
- First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsRecruitingNCT05768139Phase 1/2
- Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer SurgeryRecruitingNCT05766891Phase 2/3
- A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBCRecruitingNCT05766410Phase 2
- Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 TrialRecruitingNCT05763992Phase 2
- TAD After Chemotherapy in Locally Advanced Breast CancerRecruitingNCT05763641
- Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer PatientsRecruitingNCT05762900Phase 2
- Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus PertuzumabRecruitingNCT05760612Phase 3
- Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.RecruitingNCT05760378Phase 3
- Discovering Factors in Metastatic Breast Cancer Patients' Clinical Trial ExperiencesNot yet recruitingNCT05760183
- PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast CancerRecruitingNCT05759546Phase 2
- Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer PatientsNot yet recruitingNCT05755581Phase 1
- FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast CancerRecruitingNCT05755048Phase 3
- Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target TherapyRecruitingNCT05754502
- A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.RecruitingNCT05753657Early Phase 1
- Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel ChemotherapyRecruitingNCT05753618Phase 4
- Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast CancerRecruitingNCT05748834Phase 2
- Surufatinib Combined With Tislelizumab in the Second-line and Further Treatment of Triple-negative Breast CancerNot yet recruitingNCT05746728Phase 1/2
- Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung CancerRecruitingNCT05746325Not applicable
- Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast CancerRecruitingNCT05744687Phase 2/3
- Chemotherapy Induced Cognitive ImpairmentRecruitingNCT05740787
- Long-term Safety and Efficacy of GBG Study ParticipantsRecruitingNCT05739591
- Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast CancerRecruitingNCT05736367Not applicable
- Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced CancerRecruitingNCT05735080Phase 1/2